Novartis produces H1N1 flu vaccine

The stock price is rising today following the announcement that Novartis produces a first batch of a vaccine for the H1N1 flu, known as swine flu, for clinical trials. Novartis hopes to have the vaccine approved for sale by the end of the year.

Qadrant: Aquamit takeover offer

The takeover offer is now official. Quadrant sent me a letter to shareholders giving details of the bid. Aquamit offers CHF 86.00 per share. That's a bit lower than the range of CHF 86.65 to CHF 90.00 at which the stock has been trading today so far.